Stocks
Alto Neuroscience, Inc.ANRO
NYSEHealthcareBiotechnology$22.82
Price as of · delayed, not real-time
A clinical-stage biotechnology company developing precision medicine for mental health conditions, using biomarkers to match patients with targeted therapies. Its lead programs focus on depression and other CNS disorders, with a pipeline that investors track for its potential to address treatment-resistant patient populations.
52W Range: $6.72-$37.48
Congressional Interest in Alto Neuroscience, Inc. (ANRO)
No congressional trades have been disclosed for Alto Neuroscience, Inc. (ANRO) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading ANRO?
No congressional trades found for this stock.